abstract |
The present invention relates to A) combinations of oxazolidinones of formula (I) with B) acetylsalicylic acid (aspirin) and C) ADP receptor antagonists, in particular P 2 Y 12 purine receptor blockers, and processes for the preparation of these combinations And their use as medicaments, particularly for the prevention and / or treatment of thromboembolic disorders. |